Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial

Diabetic cardiomyopathy (DbCM) is a form of Stage B heart failure (HF) at high risk for progression to overt disease. Using baseline characteristics of study participants from the Aldose Reductase Inhibition f...

Source: Cardiovascular Diabetology - February 1, 2024 Category: Cardiology Authors: James L. Januzzi, Stefano Del Prato, Julio Rosenstock, Javed Butler, Justin Ezekowitz, Nasrien E. Ibrahim, Carolyn S.P. Lam, Thomas Marwick, W. H. Wilson Tang, Yuxi Liu, Reza Mohebi, Alessia Urbinati, Faiez Zannad and Riccardo Perfetti Tags: Research Source Type: research